Related Experiment Videos
[Sneddon syndrome and mitral valve disease]
F Puisieux1, P De Groote, A Millaire
1Service de Cardiologie C, CHRU Lille.
Annales De Cardiologie Et D'Angeiologie
|February 1, 1996
Summary
Sneddon's syndrome, a condition causing skin lesions and stroke, was observed in a patient with mitral valve disease. Antiphospholipid antibodies were negative, prompting discussion on syndrome, antibody, and valve disease relationships.
Area of Science:
- Neurology
- Cardiology
- Rheumatology
Background:
- Sneddon's syndrome is a rare condition characterized by livedo reticularis and cerebrovascular events.
- Antiphospholipid antibodies are often associated with Sneddon's syndrome and thrombotic events.
- Mitral valve disease can present with embolic complications.
Observation:
- A 37-year-old woman presented with widespread livedo and transient cerebral ischemia, consistent with Sneddon's syndrome.
- The patient had a history of mitral valve disease requiring commissurotomy.
- Testing for anticardiolipin antibodies yielded negative results.
Findings:
- The case highlights a potential association between Sneddon's syndrome and mitral valve disease.
- Negative anticardiolipin antibodies challenge the typical antiphospholipid antibody association with Sneddon's syndrome.
- The interplay between Sneddon's syndrome, antiphospholipid antibodies, and cardiac valve lesions requires further investigation.
Implications:
- This case broadens the differential diagnosis for Sneddon's syndrome, particularly in patients with valvular heart disease.
- It suggests that Sneddon's syndrome may occur in the absence of antiphospholipid antibodies.
- Further research is needed to elucidate the complex pathogenetic mechanisms linking these conditions.